Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured hepatitis C infection
Hamish Innes, Peter Jepsen, Scott McDonald, John Dillon, Victoria Hamill, Alan Yeung, Jennifer Benselin, April Went, Andrew Fraser, Andrew Bathgate, M. Azim Ansari, Stephen Barclay, David Goldberg, Peter Hayes, Philip Johnson, Eleanor Barnes, William Irving, Sharon Hutchinson, Indra Neil Guha
Hepatocellular carcinoma (HCC) prediction models can inform clinical decisions about HCC screening provided their predictions are robust. We conducted an external validation of six HCC prediction models for UK patients with cirrhosis and a hepatitis C virus (HCV) virological cure.